Annexon (ANNX) Common Equity (2019 - 2026)

Annexon's (ANNX) quarterly Common Equity came in at $204.5 million in Q1 2026, down 16.1% year-on-year from $243.8 million in Q1 2025, and down 3.36% quarter-over-quarter from $211.6 million in Q4 2025.

Annexon (ANNX) Common Equity (2019 - 2026) Analysis & Trends

Annexon's Common Equity history runs 8 years deep, the most recent figure standing at $204.5 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 16.1% year-over-year to $204.5 million in Q1 2026; TTM through Mar 2026 was $204.5 million, a 16.1% decrease from a year earlier, with the FY2025 full-year figure at $211.6 million, down 27.79% from the prior year.
  • Common Equity eased to $204.5 million in Q1 2026 per ANNX's latest filing, from $211.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $361.1 million in Q2 2024 and bottomed at $156.8 million in Q3 2023.
  • The 5-year median for Common Equity is $214.9 million (2023), against an average of $231.5 million.
  • Across the five-year window, Common Equity surged 111.4% in 2024 and plunged 51.31% in 2025, its largest moves.
  • Year by year, Common Equity stood at $231.2 million in 2022, then advanced by 8.37% to $250.6 million in 2023, then gained by 16.98% to $293.1 million in 2024, then retreated by 27.79% to $211.6 million in 2025, then dropped by 3.36% to $204.5 million in 2026.
  • Per Business Quant, the three latest ANNX Common Equity figures stand at $204.5 million (Q1 2026), $211.6 million (Q4 2025), and $161.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Annexon 1.03 Bn 804.24 Mn - 204.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 204.53 Mn
Dec 31, 2025 211.65 Mn
Sep 30, 2025 161.44 Mn
Jun 30, 2025 199.02 Mn
Mar 31, 2025 243.79 Mn
Dec 31, 2024 293.11 Mn
Sep 30, 2024 331.56 Mn
Jun 30, 2024 361.08 Mn
Mar 31, 2024 262.41 Mn
Dec 31, 2023 250.56 Mn
Sep 30, 2023 156.84 Mn
Jun 30, 2023 184.72 Mn
Mar 31, 2023 214.86 Mn
Dec 31, 2022 231.19 Mn
Sep 30, 2022 260.60 Mn
Jun 30, 2022 168.04 Mn
Mar 31, 2022 200.61 Mn
Dec 31, 2021 231.91 Mn
Sep 30, 2021 264.48 Mn
Jun 30, 2021 295.34 Mn